Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
| 0.1164 Delayed Data As of Mar 24 |  -0.0036 / -3.00%Today’s Change | 0.10 Today|||52-Week Range 0.62 | -31.25% Year-to-Date |
Latest ADMP News | Press Releases
No recent news for Adamis Pharmaceuticals Corp.
Today’s Trading
| Previous close | 0.12 |
| Today’s open | 0.12 |
| Day’s range | 0.11 - 0.12 |
| Volume | 8,576 |
| Average volume (3 months) | 1,100,052 |
| Market cap | $18.8M |
Data as of 3:45pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +44.42% |
| Earnings growth (this year) | +55.56% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +115.34% |
| P/E ratio | NM |
| Price/Sales | 5.33 |
| Price/Book | -- |
Competitors
| ---- | ||
| ZYNEZynerba Pharmaceutic... | -0.03 | -6.62% |
| AIMAIM ImmunoTech Inc | -0.02 | -4.18% |
| CYCNCyclerion Therapeuti... | -0.02 | -5.11% |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $4.8M |
| Annual profit (last year) | -$26.5M |
| Net profit margin | -550.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
